Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery

Saudi Pharmaceutical Journal

Volumn 20, Issue 4, 2012, Pages 355-363

  Malakar, Jadupati ^a   Sen, Suma Oomen ^b   Nayak, Amit Kumar ^c   Sen, Kalyan Kumar ^b  

^a Durgapur 713212   (India)

^b GUPTA COLLEGE OF TECHNOLOGICAL SCIENCES   (India)

^c SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Gel; Hypoglycemic effect; Insulin; Iontophoresis; Permeation flux; Transdermal; Transferosome

Indexed keywords

CHOLESTEROL; DEOXYCHOLATE SODIUM; DRUG CARRIER; INSULIN; LIPID; PHOSPHATIDYLCHOLINE; TRANSFEROSOME; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SCREENING; DRUG TRANSPORT; EVAPORATION; FEMALE; GEL; HYPOGLYCEMIA; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMBRANE TRANSPORT; NONHUMAN; RAT; SWINE;

EID: 84866767389     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2012.02.001     Document Type: Article

References (32)

1. Amnon C.S., Wormser U. Topical iodine facilitates transdermal delivery of insulin. J. Control. Release 2007, 118(2):185-188.
2. Benson H.A.E. Transfersomes for transdermal drug delivery. Exp. Opin. Drug Deliv. 2006, 3(6):727-737.
3. Cevc G., Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transferosomes®. Biochim. Biophys. Acta 2003, 1614:156-164.
4. Cevc G., Gebauer D., Stieber J., Schatzlein A., Blume G. Ultraflexible vesicles, Transferosomes, have an extremelly pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1998, 1368:201-215.
5. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 2003, 42:461-474.
6. thedition 2005, McGraw-Hill, New York, 1613-1616. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
7. Jain S., Umamaheshwari R.B., Bhadra D., Tripathi P., Jain P., Jain N.K. Ultra deformable liposome: a recent tool for effective transdermal drug delivery. Indian J. Pharm. Sci. 2003, 65:223-231.
8. Joshi S.A., Chavan S.S., Sawant K.K. Rivastigmine-loaded PLGA and PBCA nanoparticles: Preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur. J. Pharm. Biopharm. 2010, 76:189-199.
9. Khafagy E.S., Morishita M., Onuki Y., Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 2007, 59:1521-1546.
10. Kim M.-S., Kim J.-S., You Y.-H., Park H.-J., Lee S., Park J.-S., Woo J.-S., Hwang S.-J. Development and optimization of a novel oral controlled delivery system for tamusulosin hydrochloride using response surface methodology. Int. J. Pharm. 2007, 341:97-104.
11. King M.J., Badea I., Solomon J., Kumar P., Gaspar K.J., Foldvari M. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technol. Ther. 2002, 4:479-488.
12. Kumar R., Philip A. Modified transdermal technologies: Breaking the barriers of drug permeation via the skin. Trop. J. Pharm. Sci. 2007, 6:633-644.
13. Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic study. J. Pharm. Pharmacol. 1999, 51:1123-1124.
14. Malakar J., Sen S.O., Nayak A.K., Sen K.K. Development and evaluation of microemulsion for transdermal delivery of insulin. ISRN Pharmaceutics 2011, Article ID 780150.
15. Marschutz M.K., Bernkop-Schnurch A. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in-vitro. Biomaterials 2000, 21:1499-1507.
16. Molokhia S.A., Zhang Y., Higuchi W.I., Li S.K. Iontophoretic transport across a multiple membrane system. J. Pharm. Sci. 2008, 97:490-505.
17. Nayak A.K. Advances in therapeutic protein production and delivery. Int. J. Pharm. Pharmaceut. Sci. 2010, 2:1-5.
18. Nayak A.K., Laha B., Sen K.K. Development of hydroxyapatite-ciprofloxacin bone-implants using " Quality by design" Acta Pharm. 2011, 61:25-36.
19. Nayak A.K., Mohanty B., Sen K.K. Comparative evaluation of in vitro diclofenac sodium permeability across excised mouse skin from different common pharmaceutical vehicles. Int. J. PharmTech Res. 2010, 2:920-930.
20. Nayak A.K., Pal D. Development of pH-sensitive tamarind seed polysaccharide-alginate composite beads for controlled diclofenac sodium delivery using response surface methodology. Int. J. Biol. Macromol. 2011, 49:784-793.
21. Pandey S., Manish G., Viral D., Jarina F. Transferosomes: A novel approach for transdermal drug delivery. Der Pharm. Lett. 2009, 1:143-150.
22. Patel R., Singh S.K., Singh S., Sheth N.R., Gendle R. Development and characterization of curcumin loaded transferosome for transdermal delivery. J. Pharm. Sci. Res. 2009, 1:71-81.
23. Pillai O., Borkute S.D., Sivaprashad N., Panchagnula R. Transdermal iontophoresis of insulin: II. Physicochemical consideration. Int. J. Pharm. 2003, 254:271-280.
24. Pillai O., Panchagnula R. Transdermal iontophoresis of insulin. VI. Influence of chemical enhancer. Int. J. Pharm. 2004, 269:109-120.
25. Ratha Adhikari S.N., Nayak B.S., Nayak A.K., Mohanty B. Formulation and evaluation of buccal patches for delivery of atenolol. AAPS Pharm. Sci. Tech. 2010, 11:1038-1044.
26. Roberts M.S., Lai P.M., Cross S.E., Yoshida N.H. Mechanism of transdermal drug delivery 1997, Mercel Dekker, New York, 291-249.
27. Schubert R., Beyer K., Wolburg H. Liposomes as drug carrier. Int. J. Pharm. 2000, 194:201-207.
28. Schwartz J.B., O'connor R.E., Schnaare R.L. Optimization technique in pharmaceutical formulation and processing. Modern Pharmaceutics 2007, 607-627. Marcel Dekker Inc, New York. 4th edition. G.S. Banker, C.T. Rhodes (Eds.).
29. Semalthy A., Semalthy M., Singh R., Saraf S.K., Saraf S. Iontophoretic drug delivery system- a review. Technol. Health Care. 2007, 15:237-245.
30. Sen A., Daly M.E., Hui S.W. Transdermal insulin delivery using lipid enhanced electroporation. Biochim. Biophys. Acta. 2002, 1564:5-8.
31. Tripathi K.D. Insulin, oral hypoglycaemics and glucagon. Essentials of Medical Pharmacology. 4th edition, Chapter 18 1999, Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, India, 264-283.
32. Yang T.J., Wang X.T., Yan X.Y., Zhang O. Phospholipids deformable vesicle for buccal delivery of insulin. Chem. Pharm. Bull. 2002, 50:749-753.